Xepi is indicated for the topical treatment of impetigo due to S. aureus or S. pyogenes in adult and pediatric patients. The Food and Drug Administration (FDA) has approved Xepi (ozenoxacin cream; ...

This is a preview. Log in through your library . Publisher Information Cambridge University Press (www.cambridge.org) is the publishing division of the University of Cambridge, one of the world’s ...

THE effect of metals on the growth of bacteria has been examined by Miller, Behring, and others, and another t contribution to this subject has lately been published by Dr. Meade Bolton, in the ...

These facts are in keeping with the general impression gained from the current medical literature and recent meetings — namely, that the number of patients with malignant forms of staphylococcal ...

EXPERIMENTAL pyelonephritis in animals and clinical pyelonephritis in man have been under serious investigation at Columbia Presbyterian Medical Center for the past decade. We have been publishing and ...

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

Topical treatment of impetigo due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes in patients ≥9 months of age. Altabax contains retapamulin, a semisynthetic ...

The bacteria Staphylococcus aureus and Streptococcus pyogenes use fibronectin-binding proteins (FnBPs) anchored in their cell walls to adhere and invade host cells, but how the largely unstructured Fn ...

Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™ Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in ...